Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(1)
Other(2)

Detailed Status

unknown2
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

unknown250%
completed125%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruitingnot_applicable

Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients

NCT06915974
unknown

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study

NCT05612269
unknownnot_applicable

THE VALUE OF INTERLEUKIN 6 AS A DIAGNOSTIC MARKER IN NEONATAL SEPSIS

NCT05585957
completednot_applicable

Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease

NCT05214508

Clinical Trials (4)

Showing 4 of 4 trials
NCT06915974Not Applicable

Comparison Between Interleukin 6 and Procalcitonin in Detecting Sepsis and Incidence of Mortality in Burn ICU Patients

Recruiting
NCT05612269

SGLT2 Inhibitors and Reducing the Risk of Cancers Among Diabetics , an Observational Study

Unknown
NCT05585957Not Applicable

THE VALUE OF INTERLEUKIN 6 AS A DIAGNOSTIC MARKER IN NEONATAL SEPSIS

Unknown
NCT05214508Not Applicable

Serum Interleukin 6 in Chronic Obstructive Pulmonary Disease

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4